Evidence map›Paper›PMID 24566181›Full record

ArticleAntimicrobial agents and chemotherapy2014

Characterization of blaOXA-143 variants in Acinetobacter baumannii and Acinetobacter pittii.

Esther Zander, Rémy A Bonnin, Harald Seifert, Paul G Higgins

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Virulence · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. A Variant Carbapenem Inactivation Method (CIM) forPathogens (Basel, Switzerland) · 2022
    Article
  6. Article
  7. Diversity of Oxacillinases and Sequence Types in Carbapenem-ResistantInternational journal of environmental research and public health · 2021
    Article
  8. Carbapenemases: TransformingBiomolecules · 2020
    Review
  9. Article
  10. Comparative Genomics ofFrontiers in microbiology · 2020
    Article
  11. Article
  12. AcinetobacterAntimicrobial agents and chemotherapy · 2018
    Article
  13. Article
  14. First Report of the Carbapenemase GeneAntimicrobial agents and chemotherapy · 2017
    Article
  15. Whole-Genome Sequence of a ColombianGenome announcements · 2017
    Article
  16. Co-existence ofAntimicrobial resistance and infection control · 2017
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Esther ZanderInstitute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne, Germany.
Rémy A Bonnin
Harald Seifert
Paul G Higgins
University of Cologne · DEUniversité Paris-Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The acquired carbapenem-hydrolyzing oxacillinase (OXA) OXA-143 has thus far been detected only in Acinetobacter baumannii isolates from Brazil. The aim of this study was to characterize three OXA-143 variants: OXA-231 and OXA-253 from carbapenem-resistant A. baumannii isolates and OXA-255 in a carbapenem-susceptible Acinetobacter pittii isolate originating from Brazil, Honduras, and the United States, respectively. The 5' rapid amplification of cDNA ends (RACE) technique identified the same transcription initiation site for all blaOXA-143-like genes and revealed differences in the putative promoter regions. However, all cloned OXA-143 variants conferred carbapenem resistance on A. baumannii ATCC 17978 and OXA-255 conferred carbapenem resistance on A. pittii SH024, which was correlated with blaOXA-255 gene expression. This is the first description of OXA-143-like outside A. baumannii. Detection of OXA-143-like in the United States and Honduras indicates its dissemination through the American continent.

Indexed as

AcinetobacterAcinetobacter baumanniiAnti-Bacterial Agentsbeta-LactamasesCarbapenemsMicrobial Sensitivity TestsAnti-Bacterial Agentsbeta-LactamasesCarbapenemsoxacillinase

Identifiers

PMID24566181
PMCPMC3993222
OpenAlexW2130104974

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.